Skip to content
Q1 '26Q4 '25Q3 '25Q2 '25Q1 '25
Total Revenue by Product
Consumable revenue$21.81M+0.8%$21.63M+1.6%$21.28M+12.4%$18.93M-5.8%$20.1M+6.8%
Instrument revenue$9.72M-43.9%$17.34M+53.2%$11.32M-20.0%$14.15M+28.4%$11.02M-27.9%
Service and other revenue$5.64M$5.84M-12.6%$6.68M+10.6%$6.04M
Total Revenue by Geography
Americas$16.69M-19.4%$20.71M+14.4%$18.1M+2.3%$17.69M+8.5%$16.3M-19.2%
Asia-Pacific$9.72M+4.1%$9.34M-2.6%$9.59M-23.9%$12.61M+8.6%$11.61M+29.6%
Europe, Middle East and Africa$10.77M-26.2%$14.59M+35.7%$10.75M+13.6%$9.47M+2.5%$9.24M-8.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Questions, answered.

How does Pacific Biosciences of California break its business down?
Pacific Biosciences of California (PACB) reports total revenue by product across 3 parts — Consumable revenue, Instrument revenue and Service and other revenue. Each is extracted from the segment footnotes and tracked over time.
Where does Pacific Biosciences of California's segment data come from?
Segment breakdowns are pulled from the segment footnotes in Pacific Biosciences of California's SEC filings (the XBRL dimensional tags), so every line ties back to a reported figure. Switch between quarterly, annual, and TTM, or open any segment for its full history.